ZLD zelira therapeutics limited

News: ZLD Zelira Therapeutics Says U.S. Observational Clinical Pain Trial Receives IRB Approval

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    July 12 (Reuters) - Zelira Therapeutics Ltd (ZLD) :

    • U.S. OBSERVATIONAL CLINICAL PAIN TRIAL RECEIVES IRB APPROVAL
    • OBTAINED IRB APPROVAL FOR ITS 12 WEEK OBSERVATIONAL CLINICAL STUDY CLINICAL PAIN TRIAL
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
38.0¢
Change
0.000(0.00%)
Mkt cap ! $4.520M
Open High Low Value Volume
38.0¢ 38.0¢ 38.0¢ $25 67

Buyers (Bids)

No. Vol. Price($)
3 34167 38.0¢
 

Sellers (Offers)

Price($) Vol. No.
40.0¢ 172 1
View Market Depth
Last trade - 13.54pm 17/09/2025 (20 minute delay) ?
ZLD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.